AL
RARE icon

Airain Ltd’s Ultragenyx Pharmaceutical RARE Stock Holding History

Airain Ltd’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$224K Buy
+3,602
New +$217K 0.01% 727

Other funds holding RARE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Airain Ltd's RARE Position: Q2 2017 in Review

Airain Ltd opened a new position in Ultragenyx Pharmaceutical (RARE) in Q2 2017: 3,602 shares worth $224K. The stake represents 0.01% of the portfolio and ranks #727 among its holdings.

158 funds tracked by Wall St. Rank hold RARE as of Q2 2017.

  • Airain Ltd held 3,602 shares of Ultragenyx Pharmaceutical worth $224K as of Q2 2017.
  • Ultragenyx Pharmaceutical was a new Airain Ltd position in Q2 2017.
  • Ultragenyx Pharmaceutical made up 0.01% of Airain Ltd's portfolio in Q2 2017, its #727 holding.
  • 158 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.